These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35353778)

  • 1. The Arched Rainbow Brow in Thyroid Eye Disease.
    Tran AQ; Yang C; Tooley AA; Mahan M; Jamerson EC; Kazim M; Dagi Glass LR
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):469-474. PubMed ID: 35353778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-dimensional construct of the aging eyebrow: the illusion of volume loss.
    Papageorgiou KI; Mancini R; Garneau HC; Chang SH; Jarullazada I; King A; Forster-Perlini E; Hwang C; Douglas R; Goldberg RA
    Aesthet Surg J; 2012 Jan; 32(1):46-57. PubMed ID: 22231412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical Modeling of Eyebrow Curvature.
    Tran AQ; Yang C; Tooley AA; Kazim M; Glass LRD
    Facial Plast Surg; 2022 Jun; 38(3):307-310. PubMed ID: 35114713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Browplasty and browpexy: an adjunct to blepharoplasty.
    McCord CD; Doxanas MT
    Plast Reconstr Surg; 1990 Aug; 86(2):248-54. PubMed ID: 2367574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Brow Fat Pad Suspension Suture: Safety Profile and Clinical Observations.
    Eftekhari K; Peng GL; Landsberger H; Douglas R; Massry GG
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):7-12. PubMed ID: 27941471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
    Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease.
    Eiger-Moscovich M; Stiebel-Kalish H; Yassur I; Barash D; Gaton D; Avisar I
    Can J Ophthalmol; 2019 Aug; 54(4):426-430. PubMed ID: 31358139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of asymmetric proptosis during the active phase of thyroid eye disease.
    Tran AQ; Zhou HW; Nanda T; Godfrey KJ; Tooley AA; North VS; Kazim M
    Orbit; 2023 Jun; 42(3):251-255. PubMed ID: 35801656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease.
    Campbell AA; Nanda T; Oropesa S; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):238-242. PubMed ID: 30234838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between bilateral and unilateral thyroid eye disease.
    Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
    Int Ophthalmol; 2023 Aug; 43(8):2957-2962. PubMed ID: 37067696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.
    Naik MN; Vasanthapuram VH
    Int Ophthalmol; 2021 Jan; 41(1):231-236. PubMed ID: 32844239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumization of the Brow at the Time of Blepharoplasty: Treating the Eyebrow Fat Pad as an Independent Unit.
    Vrcek I; Chou E; Somogyi M; Shore JW
    Ophthalmic Plast Reconstr Surg; 2018; 34(3):209-212. PubMed ID: 28369020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of pediatric thyroid eye disease: the Asian experience.
    Sim B; Chng CL; Audrey C; Seah LL
    Orbit; 2022 Feb; 41(1):69-78. PubMed ID: 33059514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The male eyebrow: a topographic anatomic analysis.
    Goldstein SM; Katowitz JA
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):285-91. PubMed ID: 16052142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of 80-year-old and older thyroid eye disease patients.
    Levy N; Leiba H; Landau K; Zloto O; Huna-Baron R
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2727-2736. PubMed ID: 35338398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eyebrow tissue expansion: an underappreciated entity in thyroid-associated orbitopathy.
    Savar LM; Menghani RM; Chong KK; Chokron Garneau H; Goldberg RA
    Arch Ophthalmol; 2012 Dec; 130(12):1566-9. PubMed ID: 23229698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection.
    Prat MC; Braunstein AL; Dagi Glass LR; Kazim M
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):215-8. PubMed ID: 25198394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teprotumumab for the treatment of thyroid eye disease.
    Fallahi P; Ragusa F; Paparo SR; Elia G; Balestri E; Mazzi V; Patrizio A; Botrini C; Benvenga S; Ferrari SM; Antonelli A
    Expert Opin Biol Ther; 2023 Feb; 23(2):123-131. PubMed ID: 36695097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.